27 |
Clinical Outcomes for Drug-Eluting Stents in LMT Lesions |
Toshiya Muramatsu |
Jul. 14. 06 |
26 |
LM Bifurcation Intervention Guideline for COMBAT |
Seung-Jung Park |
Jul. 14. 06 |
25 |
Revised Protocol of COMBAT(Randomized COMparison of Bypass Surgery versus AngioplasTy using Sirolimus-Eluting Stent in Patients with Left Main Coronary Artery Disease) |
Roxana Mehran |
Jul. 14. 06 |
24 |
French Pilot Registry of Unprotected LM Stenting with Taxus Stents, One Year Follow Up [1] |
Marc Silvestri |
Jul. 14. 06 |
23 |
Drug Eluting Stents (Bifurcation and Left Main Approach) |
Eberhard Grube |
Jun. 30. 06 |
22 |
Countdown to COMBAT |
Roxana Mehran |
May. 26. 06 |
21 |
LM stenting -TAXUS |
Marc Silvestri |
Aug. 25. 05 |
20 |
LM stenting -Cypher |
Seung-Jung Park |
Aug. 25. 05 |
19 |
Management of Non-Protected Left Main Bifurcation Without DES |
Masahiko Ochiai |
Aug. 25. 05 |
18 |
Medium Term Follow-up of Drug-Eluting Stents in Left Main Bifurcation Stenosis |
Teguh Santoso |
Aug. 25. 05 |